| Financial Year |
March 31 2023 |
| Monetary Funds |
117,589,322.94 |
| Held-for-trading Financial Assets |
23,265,100.00 |
| Notes Receivable |
3,793,888.65 |
| Accounts Receivable |
215,823,168.98 |
| Advances to Suppliers |
124,242,879.42 |
| Other Receivables |
50,208,593.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,433,490,851.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,559,598.64 |
| Total Current Assets |
2,661,026,191.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
272,394,959.97 |
| Investment Properties |
-- |
| Fixed Assetes |
309,517,141.39 |
| Under-construction Projects |
29,701,047.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,525,799.55 |
| R&D expenses |
-- |
| Goodwill |
519,722,758.18 |
| Long-Term Deferred and Prepaid Expenses |
10,444,774.81 |
| Deferred Income Tax Assets |
88,282,520.92 |
| Other Non-Current Assets |
289,999,850.00 |
| Sub-Total of Non-Current Assets |
1,855,829,769.35 |
| Total Assets |
4,516,855,961.29 |
| Short-Term Loans |
269,932,354.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,777,231.17 |
| Accounts Payable |
802,204,675.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,741,728.14 |
| Taxes Payable |
29,211,652.14 |
| Interest Payable |
-- |
| Dividend Payable |
2,669,210.56 |
| Other payables |
685,663,345.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,641,118.18 |
| Other Current Liabilities |
115,993,995.85 |
| Sub-Total of Current Liabilities |
2,952,603,571.25 |
| Long-term Loans |
217,450,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
107,764,325.62 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
120,059,873.90 |
| Sub-Total of Non-Current Liabilities |
449,499,816.72 |
| Total Liabilities |
3,402,103,387.97 |
| Paid-In Capital(Or Share Stock) |
760,937,577.00 |
| Capital Surplus |
1,205,043,105.15 |
| Surplus Reserve |
86,019,272.83 |
| LESS:Treasury Stock |
999,500.00 |
| Undistributed Profits |
-981,782,611.41 |
| Minority Stockholder's Interest |
75,381,468.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,039,371,104.92 |
| Owner's Equity（Stockholder's Equity） |
1,114,752,573.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,516,855,961.29 |
